Royal London Asset Management LTD Amgen Inc Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Royal London Asset Management LTD holds 229,366 shares of AMGN stock, worth $66 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

229,366

Previous 222,919 2.89%

Holding current value

$66 Million

Previous $69.7 Million 6.11%

% of portfolio

0.19%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.99 Million - $2.18 Million	6,447 Added 2.89%	229,366 $73.9 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $1.42 Million - $1.72 Million	5,389 Added 2.48%	222,919 $69.7 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $292,261 - $352,796	-1,087 Reduced 0.5%	217,530 $61.8 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $124,270 - $140,191	-486 Reduced 0.22%	218,617 $63 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $3.7 Million - $4.59 Million	16,910 Added 8.36%	219,103 $58.9 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $2.34 Million - $2.77 Million	10,930 Added 5.71%	202,193 $44.9 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $928,900 - $1.13 Million	4,114 Added 2.2%	191,263 $46.2 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $1.36 Million - $1.72 Million	5,919 Added 3.27%	187,149 $49.2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $4.47 Million - $5.05 Million	-19,934 Reduced 9.91%	181,230 $40.9 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.34 Million - $1.48 Million	6,098 Added 3.13%	201,164 $48.6 Million
Q4 2021 Oct 18, 2022	SELL	$198.88 - $227.6 $1.93 Million - $2.21 Million	-9,694 Reduced 4.73%	195,066 $43.9 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $1.93 Million - $2.21 Million	-9,694 Reduced 4.73%	195,066 $43.9 Million
Q3 2021 Oct 18, 2022	SELL	$212.27 - $248.7 $1.32 Million - $1.54 Million	-6,202 Reduced 2.94%	204,760 $43.5 Million
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $1.32 Million - $1.54 Million	-6,202 Reduced 2.94%	204,760 $43.5 Million
Q2 2021 Oct 18, 2022	BUY	$233.58 - $259.14 $2.29 Million - $2.54 Million	9,798 Added 4.87%	210,962 $51.4 Million
Q2 2021 Jul 14, 2021	SELL	$233.58 - $259.14 $1.03 Million - $1.15 Million	-4,419 Reduced 2.05%	210,962 $51.4 Million
Q1 2021 Oct 17, 2022	BUY	$221.91 - $258.6 $3.15 Million - $3.68 Million	14,217 Added 7.07%	215,381 $53.6 Million
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $130,704 - $152,315	589 Added 0.27%	215,381 $53.6 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $2.75 Million - $3.27 Million	-12,709 Reduced 5.59%	214,792 $49.4 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $623,230 - $693,083	-2,656 Reduced 1.15%	227,501 $56.5 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $1.6 Million - $1.96 Million	-8,074 Reduced 3.39%	230,157 $53.3 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $292,130 - $387,445	-1,603 Reduced 0.67%	238,231 $49.7 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $194,697 - $250,252	1,029 Added 0.43%	239,834 $57.6 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $41.6 Million - $49.8 Million	238,805 New	238,805 $46.2 Million
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $41.8 Million - $49 Million	-250,821 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $3.97 Million - $4.47 Million	-21,931 Reduced 8.04%	250,821 $0
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $2.41 Million - $2.81 Million	13,494 Added 5.2%	272,752 $52 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $6.69 Million - $7.54 Million	-36,116 Reduced 12.23%	259,258 $0
Q2 2018 Sep 19, 2018	BUY	$166.05 - $186.51 $49 Million - $55.1 Million	295,374 New	295,374 $54.5 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Amgen Inc Transaction History